EUVIMEDEUVIMED entdecken
Crossref

Structural basis for pan-coronavirus inhibition of 3CL protease

Eswar R Reddem, Farhad Forouhar, Cheng Liu, Sarah K Stevens, Andreas Jekle, Ching-Wen Chang, Neelam Oswal, David C McGowan, Koen Vandyck, David B Smith, Pierre Raboisson, Leonid N Beigelman und 8 weitere

Structure · 2026

DOI: 10.1016/j.str.2026.01.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Structure, 2026. Verfasst von Eswar R Reddem und 19 weiteren Autor:innen. Beteiligte Einrichtung: Zuckerman Mind Brain Behavior Institute, Columbia University, New York, NY 10027, USA. Hauptthemen laut MEDLINE: Antiviral Agents, Protease Inhibitors, Coronavirus. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Institute of Allergy and Infectious Diseases Division of Intramural Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epidemic and pandemic outbreaks of respiratory illness caused by three different coronaviruses over the past two decades have underscored the importance of pharmaceutical agents that could offer broad-spectrum activity across this family of pathogens. Two coronavirus inhibitors characterized by broad in vitro potency were synthesized and studied with X-ray crystallography. Their high-resolution structures in complex with six α-, β-, and γ-coronaviruses delineate the requirements for pan-coronavirus inhibition by drug-like molecules targeting the S1-S4 subsites of the viral 3CL-protease, which performs a critical function during coronavirus polyprotein processing. Anchoring by polar contacts in S1, utilization of hydrophobic packing in S2, compact substitutions in S3, and mid-sized hydrophobic modifications in S4 are all factors contributing to inhibitor activity. Interactions in S2 are modulated by the amino acid identity of three key residues, and in S4, where sequence conservation is the lowest, pan-coronavirus coverage is facilitated by solvent exposure of the diverging side chains.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsProtease InhibitorsCoronavirusCrystallography, X-RayModels, MolecularHumansCoronavirus 3C ProteasesSARS-CoV-2Protein BindingHydrophobic and Hydrophilic Interactions

Stichwörter der Autor:innen

3CL protease inhibitorCOVID-19SARS-CoV-2pan-coronavirus inhibitionstructure-based drug design

Substanzen

Antiviral AgentsCoronavirus 3C ProteasesProtease Inhibitors

Autor:innen und Institutionen

  • Zuckerman Mind Brain Behavior Institute, Columbia University, New York, NY 10027, USA.
  • Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY 10032, USA.
  • Aligos Therapeutics, Inc., 1 Corporate Drive, 2nd Floor, South San Francisco, CA 94080, USA.
  • Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ, USA.
  • Aligos Belgium BV, Gaston Geenslaan 1, 3001 Leuven, Belgium.
  • Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ, USA; Department of Medical Sciences, Hackensack Meridian School of Medicine, Nutley, NJ, USA.

Förderung

  • National Institute of Allergy and Infectious Diseases Division of Intramural Research

Zitieren

APA

Reddem, E. R., Forouhar, F., Liu, C., Stevens, S. K., Jekle, A., Chang, C. W., Oswal, N., McGowan, D. C., Vandyck, K., Smith, D. B., Raboisson, P., Beigelman, L. N., Katsamba, P. S., Bahna, F., Mannepalli, S., Blatt, L., Perlin, D., Symons, J. A., Shapiro, L., & Stoycheva, A. D. (2026). Structural basis for pan-coronavirus inhibition of 3CL protease. Structure. https://doi.org/10.1016/j.str.2026.01.003

Vancouver

Reddem ER, Forouhar F, Liu C, Stevens SK, Jekle A, Chang CW, et al. Structural basis for pan-coronavirus inhibition of 3CL protease. Structure. 2026. doi:10.1016/j.str.2026.01.003

BibTeX
@article{Reddem2026,
  author = {Reddem, Eswar R and Forouhar, Farhad and Liu, Cheng and Stevens, Sarah K and Jekle, Andreas and Chang, Ching-Wen and Oswal, Neelam and McGowan, David C and Vandyck, Koen and Smith, David B and Raboisson, Pierre and Beigelman, Leonid N and Katsamba, Phinikoula S and Bahna, Fabiana and Mannepalli, Seetha and Blatt, Lawrence and Perlin, David and Symons, Julian A and Shapiro, Lawrence and Stoycheva, Antitsa D},
  title = {Structural basis for pan-coronavirus inhibition of 3CL protease},
  journal = {Structure},
  year = {2026},
  doi = {10.1016/j.str.2026.01.003}
}
Kostenlos starten →